Advertisement

Topics

NanoBio Corp. Company Profile

14:52 EDT 23rd September 2017 | BioPortfolio

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat® technology platform. The company’s lead product candidates are treatments for herpes labialis, onychomycosis, vaginitis, cystic fibrosis and a broad platform of intranasal vaccines. The company’s headquarters and laboratory facilities are located in Ann Arbor, Michigan.


News Articles [47 Associated News Articles listed on BioPortfolio]

NanoBio Corporation And Receive Approval To Advance Next Generation Anthrax Vaccine

  Life Sciences Jobs   ...

NanoBio And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine

ANN ARBOR, Mich., June 19, 2017 /PRNewswire/ -- NanoBio Corporation today announced the progression of a novel intranasal anthrax vaccine into a pre-clinical IND-enabling toxicology study funded ...

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

GTX Corp Receives Military Contract

LOS ANGELES, CALIFORNIA , Sept. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive ...

GTX Corp Partners with ORBCOMM to Enable GPS SmartSoles on the Verizon Network

LOS ANGELES, CALIFORNIA , Sept. 12, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive te...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, tod...

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today...

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will presen...

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

Molecular Interactions between Graphene and Biological Molecules.

Applications of graphene have extended into areas of nanobio-technology such as nanobio-medicine, nanobio-sensing, as well as nanoelectronics with biomolecules. These applications involve interactions...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

It's all about Time.

New knowledge on multi-scale temporal dynamics linking nanobio-time series, seasonal changes, immune response, and gut mictobiota can milestone (neuro)science soon.

Graphene-supporting films and low-voltage STEM in SEM toward imaging nanobio materials without staining: Observation of insulin amyloid fibrils.

Utilization of graphene-supporting films and low-voltage scanning transmission electron microscopy (LV-STEM) in scanning electron microscopy (SEM) is shown to be an effective means of observing unstai...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [40 Associated Companies listed on BioPortfolio]

NanoBio Corp.

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal v...

Nanobiotix

NanoBio® Corp. is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccine...

NanoBio Corporation

NanoBio Corporation is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vacci...

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

More Information about "NanoBio Corp." on BioPortfolio

We have published hundreds of NanoBio Corp. news stories on BioPortfolio along with dozens of NanoBio Corp. Clinical Trials and PubMed Articles about NanoBio Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NanoBio Corp. Companies in our database. You can also find out about relevant NanoBio Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cystic Fibrosis
Affecting over 8,500 people in the UK, Cystic Fibrosis (CF) is one of the UK's most common life-threatening inherited diseases. Around half of the CF population can expect to live over 38 years, although improvements in treatments mean a baby born ...


Corporate Database Quicklinks



Searches Linking to this Company Record